Welcome to MedArena!

Your trusted destination for CME, CPD & Medical Education across the Middle East.

Information

  • Address:MedArena Corporation
  • Call Us:1 (800) 828-2059
  • Email:support [at] medarenaevents.com
Dr. Ben Mizukawa

Achievements

—Pediatric hematology-oncology expertise:
—Therapeutic-target research:

Dr. Ben Mizukawa

Research Director, Pediatric Cancer Avatar Program; Associate Professor

Cincinnati Children’s Hospital

About

Dr. Ben Mizukawa is the Research Director of the Pediatric Cancer Avatar Program and an Associate Professor in the UC Department of Pediatrics at Cincinnati Children’s Hospital, USA.

Dr. Ben Mizukawa is a physician-scientist and academic researcher affiliated with Cincinnati Children’s Hospital Medical Center and the University of Cincinnati Department of Pediatrics in the United States. His work focuses on pediatric cancer research, particularly the biological mechanisms underlying leukemia and other blood cancers, with an emphasis on understanding disease progression and identifying potential therapeutic approaches.

Dr. Mizukawa is identified as the Research Director of the Pediatric Cancer Avatar Program and an Associate Professor. His research background includes hematologic malignancies, stem-cell biology, leukemia models, and investigations into how cancer cells survive, develop resistance to treatment, and contribute to relapse.

A major area of his scientific work involves studying acute myeloid leukemia (AML) and other leukemias. His research has explored cellular signaling pathways, including the roles of small GTPases such as CDC42 and RAC in leukemia-cell behavior. These pathways are relevant to cancer-cell survival, division, differentiation, and interactions with the bone-marrow environment.

Dr. Mizukawa has also contributed to research using preclinical models of leukemia and patient-derived xenograft models to investigate disease biology and evaluate potential treatments. This work supports efforts to improve understanding of difficult-to-treat pediatric cancers and to develop more targeted therapeutic strategies.

His academic contributions include peer-reviewed publications and collaborative research with investigators in hematology, oncology, and cancer biology. Through his research and academic responsibilities, he contributes to the broader effort to improve scientific understanding of childhood cancer and advance future treatment approaches.

Institution

Cincinnati Children’s Hospital Medical Center

Dr. Mizukawa is affiliated with the hospital’s Cancer and Blood Diseases Institute. He also holds an academic appointment in the University of Cincinnati Department of Pediatrics.

Achievement Timeline

2004 – Medical Degree

Earned his Doctor of Medicine (MD) from the University of Utah School of Medicine.

2004–2007 – Pediatric Residency

Completed pediatric residency training at Cincinnati Children’s Hospital Medical Center.

2007–2010 – Pediatric Hematology and Oncology Fellowship

Completed subspecialty fellowship training at Cincinnati Children’s, developing expertise in childhood blood disorders and cancers.

2008–2011 – Pediatric Scientist Development

Participated in the Pediatric Scientist Development Program, supporting his development as a physician-scientist pursuing research in pediatric hematology and oncology.

2008 – Pediatrics Certification

Achieved board certification in pediatrics.

2011 – Pediatric Hematology-Oncology Certification

Achieved board certification in pediatric hematology-oncology.

2010s – Leukemia and Cancer Biology Research

Contributed to studies investigating the molecular pathways involved in leukemia development, including RAC and CDC42 signaling, leukemia-cell survival, and the biology of leukemic stem cells.

2017 – Research on Leukemia Cell Division

Co-authored research published in Blood examining how CDC42 influences cell polarity and division symmetry in acute myeloid leukemia, helping advance understanding of mechanisms that may contribute to leukemia progression.

2021 – Research on Genomically Targeted Treatment Access

Co-authored a multicenter study published in the Journal of Clinical Oncology examining requests for targeted investigational therapies for children and adolescents with cancer.

2022 – Leukemia Signaling Research

Contributed to collaborative research published in Nature Communications investigating molecular mechanisms involved in B-cell lymphoblastic leukemia.

2023–2024 – Continued Pediatric Cancer Research

Contributed to publications addressing treatment approaches for pediatric and young-adult blood cancers, including leukemia and lymphoma.

Current Professional Role

Serves as Research Director of the Pediatric Cancer Avatar Program and Associate Professor in the University of Cincinnati Department of Pediatrics, with ongoing interests in pediatric leukemia, lymphoma, and experimental models for evaluating potential treatments.

Major Achievements and Contributions

  1. Pediatric hematology-oncology expertise: Completed specialist training and obtained board certification in pediatric hematology-oncology.
  2. Leukemia research: Contributed to scientific studies examining the cellular and molecular mechanisms responsible for leukemia development and progression.
  3. Therapeutic-target research: Participated in investigations of signaling pathways that may offer opportunities for developing targeted leukemia treatments.
  4. Preclinical disease modeling: Contributed to research using xenograft models to investigate pediatric leukemia and evaluate potential therapeutic strategies.
  5. Collaborative scientific publications: Co-authored peer-reviewed research in journals including Blood, Nature Communications, and the Journal of Clinical Oncology.
  6. Academic leadership: Holds a research leadership role in the Pediatric Cancer Avatar Program while maintaining an academic appointment in pediatrics.

Awards and Recognition

Dr. Mizukawa’s documented professional recognition includes his board certifications in pediatrics and pediatric hematology-oncology, as well as his appointment to a research leadership position at Cincinnati Children’s Hospital Medical Center.

Events & Activities

20th SEHA International Pediatric Conference (SIPC 2026)
Oct 16, 2026
In-Person
Oct 16, 2026
In-Person

20th SEHA International Pediatric Conference (SIPC 2026)

Free

The 20th SEHA International Pediatric Conference (SIPC 2026), co-hosted by Cincinnati Children’s Hospital, is a premier event showcasing the latest advancements in pediatric care.

MENA Conference

  • 3 Days
  • Abu Dhabi, UAE
CME Certified Courses
Medical Education Hub
Expert Medical Speakers
AI-Powered Learning
Accredited Certificates
Live Medical Events
Continuous Medical Education
CME Certified Courses
Medical Education Hub
Expert Medical Speakers
AI-Powered Learning
Accredited Certificates
Live Medical Events
Continuous Medical Education
CME Certified Courses
Medical Education Hub
Expert Medical Speakers
AI-Powered Learning
Accredited Certificates
Live Medical Events
Continuous Medical Education
Speaker not found | MedArena